159 related articles for article (PubMed ID: 33349674)
1. Distinct trajectories of response to prefrontal tDCS in major depression: results from a 3-arm randomized controlled trial.
Goerigk SA; Padberg F; Bühner M; Sarubin N; Kaster TS; Daskalakis ZJ; Blumberger DM; Borrione L; Razza LB; Brunoni AR
Neuropsychopharmacology; 2021 Mar; 46(4):774-782. PubMed ID: 33349674
[TBL] [Abstract][Full Text] [Related]
2. Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial.
Moreno ML; Goerigk SA; Bertola L; Suemoto CK; Razza LB; Moffa AH; Veronezi BP; Tort L; Nogueira BS; Gattaz WF; Fraguas R; Padberg F; Lotufo PA; Benseñor IM; Brunoni AR
J Affect Disord; 2020 Feb; 263():344-352. PubMed ID: 31969264
[TBL] [Abstract][Full Text] [Related]
3. Parsing the antidepressant effects of non-invasive brain stimulation and pharmacotherapy: A symptom clustering approach on ELECT-TDCS.
Goerigk SA; Padberg F; Chekroud A; Kambeitz J; Bühner M; Brunoni AR
Brain Stimul; 2021; 14(4):906-912. PubMed ID: 34048940
[TBL] [Abstract][Full Text] [Related]
4. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Brunoni AR; Moffa AH; Sampaio-Junior B; Borrione L; Moreno ML; Fernandes RA; Veronezi BP; Nogueira BS; Aparicio LVM; Razza LB; Chamorro R; Tort LC; Fraguas R; Lotufo PA; Gattaz WF; Fregni F; Benseñor IM;
N Engl J Med; 2017 Jun; 376(26):2523-2533. PubMed ID: 28657871
[TBL] [Abstract][Full Text] [Related]
5. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: Evidence from the ELECT-TDCS trial.
Bulubas L; Padberg F; Bueno PV; Duran F; Busatto G; Amaro E; Benseñor IM; Lotufo PA; Goerigk S; Gattaz W; Keeser D; Brunoni AR
Brain Stimul; 2019; 12(5):1197-1204. PubMed ID: 31105027
[TBL] [Abstract][Full Text] [Related]
7. The Escitalopram versus Electric Current Therapy for Treating Depression Clinical Study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial.
Brunoni AR; Sampaio-Junior B; Moffa AH; Borrione L; Nogueira BS; Aparício LV; Veronezi B; Moreno M; Fernandes RA; Tavares D; Bueno PV; Seibt O; Bikson M; Fraguas R; Benseñor IM
Sao Paulo Med J; 2015; 133(3):252-63. PubMed ID: 26176930
[TBL] [Abstract][Full Text] [Related]
8. Prefrontal resting-state connectivity and antidepressant response: no associations in the ELECT-TDCS trial.
Bulubas L; Padberg F; Mezger E; Suen P; Bueno PV; Duran F; Busatto G; Amaro E; Benseñor IM; Lotufo PA; Goerigk S; Gattaz W; Keeser D; Brunoni AR
Eur Arch Psychiatry Clin Neurosci; 2021 Feb; 271(1):123-134. PubMed ID: 32880057
[TBL] [Abstract][Full Text] [Related]
9. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression.
Brunoni AR; Padberg F; Vieira ELM; Teixeira AL; Carvalho AF; Lotufo PA; Gattaz WF; Benseñor IM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():211-217. PubMed ID: 29894705
[TBL] [Abstract][Full Text] [Related]
10. Bifrontal-transcranial direct current stimulation as an early augmentation strategy in major depressive disorder: A single-blind randomised controlled trial.
Kumari B; Singh A; Kar SK; Tripathi A; Agarwal V
Asian J Psychiatr; 2023 Aug; 86():103637. PubMed ID: 37270874
[TBL] [Abstract][Full Text] [Related]
11. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.
Bajbouj M; Aust S; Spies J; Herrera-Melendez AL; Mayer SV; Peters M; Plewnia C; Fallgatter AJ; Frase L; Normann C; Behler N; Wulf L; Brakemeier EL; Padberg F
Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):797-808. PubMed ID: 29214483
[TBL] [Abstract][Full Text] [Related]
12. White matter predicts tDCS antidepressant effects in a sham-controlled clinical trial study.
Zanao TA; Luethi MS; Goerigk S; Suen P; Diaz AP; Soares JC; Brunoni AR
Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1421-1431. PubMed ID: 36336757
[TBL] [Abstract][Full Text] [Related]
13. Home-Use Transcranial Direct Current Stimulation for the Treatment of a Major Depressive Episode: A Randomized Clinical Trial.
Borrione L; Cavendish BA; Aparicio LVM; Luethi MS; Goerigk S; Ramos MRF; Moran NKS; Carneiro AM; Valiengo L; Moura DO; de Souza JP; Batista MP; Aparecida da Silva V; Klein I; Suen P; Gallucci-Neto J; Padberg F; Razza LB; Vanderhasselt MA; Lotufo PA; Bensenor IM; Fregni F; Brunoni AR
JAMA Psychiatry; 2024 Apr; 81(4):329-337. PubMed ID: 38170541
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
Brown ES; Howard C; Khan DA; Carmody TJ
Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
[TBL] [Abstract][Full Text] [Related]
15. International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH;
Brain Stimul; 2018; 11(1):125-133. PubMed ID: 29111077
[TBL] [Abstract][Full Text] [Related]
16. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.
Kaster TS; Downar J; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Blumberger DM
Am J Psychiatry; 2019 May; 176(5):367-375. PubMed ID: 30764649
[TBL] [Abstract][Full Text] [Related]
17. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study.
Papakostas GI; Fava M; Baer L; Swee MB; Jaeger A; Bobo WV; Shelton RC
Am J Psychiatry; 2015 Dec; 172(12):1251-8. PubMed ID: 26085041
[TBL] [Abstract][Full Text] [Related]
18. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
[TBL] [Abstract][Full Text] [Related]
19. Patient Response Trajectories in Major Depressive Disorder.
Larsen KG; Kennedy SH; Reines EH; Thase ME
Psychopharmacol Bull; 2020 Sep; 50(4):8-28. PubMed ID: 33012870
[TBL] [Abstract][Full Text] [Related]
20. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
